Healthcare / Medical Care FacilitiesThailand
$1.31
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $624.6M · quality 68.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
41/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.3B
P/E
2.1x
↓EV/EBITDA
2.3x
↓ROE
54.4%
↑Gross Margin
17.3%
↓Debt/Equity
0.49
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-21.7%
FCF CAGR
-49.8%
FCF margin
3.8%
FCF / Net income
0.04x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.50B · net income $2.45B · FCF $95.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.50B | $2.50B | $2.55B | $5.07B | $5.20B |
| Net Income | $2.45B | $2.45B | $130.5M | $217.8M | $503.9M |
| EBITDA | $3.12B | $3.12B | $553.8M | $1.13B | $1.42B |
| EPS | 0.60 | 0.60 | 0.03 | 0.05 | 0.13 |
| Gross Margin | 17.3% | 17.3% | 18.5% | 22.7% | 27.1% |
| Operating Margin | 9.7% | 9.7% | 3.2% | 10.2% | 15.7% |
| Net Margin | 98.0% | 98.0% | 5.1% | 4.3% | 9.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.49 | 0.49 | 0.93 | 0.85 | 0.80 |
| Current Ratio | 0.26 | 0.26 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $95.1M | $95.1M | $624.6M | $627.0M | $750.6M |
| Returns | |||||
| ROE | 54.4% | 54.4% | 3.5% | 5.0% | 10.1% |
| Valuation | |||||
| P/E | 2.11 | 2.11 | 56.00 | 48.40 | 21.21 |
| EV/EBITDA | 2.27 | 2.27 | 18.19 | 11.72 | 10.45 |
| P/B | 1.19 | 1.19 | 1.81 | 2.24 | 2.22 |
| Growth & Yield | |||||
| Revenue Growth | -2.0% | -2.0% | -49.7% | -2.7% | — |
| EPS Growth | 1900.0% | 1900.0% | -40.0% | -61.5% | — |
| Dividend Yield | 20.6% | 20.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-42.1%
EPS terminal req.
$0.12
Spread vs growth
1942.1%
5Y implied EPS CAGR
-25.2%
EPS terminal req.
$0.14
Spread vs growth
1925.2%
10Y implied EPS CAGR
-9.3%
EPS terminal req.
$0.23
Spread vs growth
1909.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+17.9%
Start / end P/E
44.7x → 2.2x
EPS bridge
0.03 → 0.60
Residual
-1807.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.